Catherine Schulte

Stock Analyst at Baird

(1.84)
# 1144
Out of 5,329 analysts
137
Total ratings
49.52%
Success rate
6.42%
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
EXAS Exact Sciences
Maintains: Outperform
69 72
53.73 34% 14 May 2, 2025
AVTR Avantor
Maintains: Outperform
21 17
13.23 28.5% 11 Apr 28, 2025
TMO Thermo Fisher Scient...
Maintains: Outperform
603 573
427.46 34.05% 26 Apr 24, 2025
DHR Danaher
Maintains: Outperform
231 225
200.6 12.16% 8 Apr 23, 2025
MTD Mettler-Toledo Intl
Maintains: Neutral
1369 1034
1089.95 -5.13% 8 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 43
43.29 -0.67% 4 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
161 159
108.89 46.02% 15 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
9 3
2.08 44.23% 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
88 68
50.95 33.46% 9 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
182 165
n/a n/a 6 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 38
19.33 96.59% 7 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
56 33
39.5 -16.46% 3 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 1 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
335 281
78.38 258.51% 6 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
21
n/a n/a 1 May 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 29
n/a n/a 5 Apr 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
208 217
351.7 -38.3% 7 Oct 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 20
155.6 -87.15% 1 Jun 28, 2018